` BWAY (Brainsway Ltd) vs Tel Aviv 355 Comparison - Alpha Spread

BWAY
vs
Tel Aviv 355

Over the past 12 months, BWAY has significantly outperformed Tel Aviv 355, delivering a return of 64% compared to the Tel Aviv 355's 32% growth.

Stocks Performance
BWAY vs Tel Aviv 355

Loading
BWAY
Tel Aviv 355
Add Stock

Performance Gap
BWAY vs Tel Aviv 355

Loading
BWAY
Tel Aviv 355
Difference

Performance By Year
BWAY vs Tel Aviv 355

Loading
BWAY
Tel Aviv 355
Add Stock

Competitors Performance
Brainsway Ltd vs Peers

Tel Aviv 355
BWAY
ABT
ISRG
BSX
SYK
Add Stock

Brainsway Ltd
Glance View

Market Cap
516.5m ILS
Industry
Health Care

Brainsway Ltd. is a commercial stage medical device company, which focuses on the development and sale of non-invasive neuromodulation products using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The firm primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.

BWAY Intrinsic Value
1 631.45 ILS
Undervaluation 4%
Intrinsic Value
Price
B
Back to Top